USP16 Antibody (OTI1B4)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-46305
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat, Canine, Monkey
Applications
Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2A Clone # OTI1B4
Concentration
1 mg/ml
Product Specifications
Immunogen
Human recombinant protein fragment corresponding to amino acids 137-466 of human USP16(NP_001001992) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Scientific Data Images for USP16 Antibody (OTI1B4)
Western Blot: USP16 Antibody (OTI1B4) [NBP2-46305]
Western Blot: USP16 Antibody (1B4) [NBP2-46305] - E.coli lysate (5 ug, left lane) and E.coli lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 137-466 of human USP16(NP_001001992) were separated by SDS-PAGE and immunoblotted with USP16.Western Blot: USP16 Antibody (OTI1B4) [NBP2-46305]
Western Blot: USP16 Antibody (1B4) [NBP2-46305] - Analysis of extracts (35ug) from 9 different cell lines (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).Applications for USP16 Antibody (OTI1B4)
Application
Recommended Usage
Western Blot
1:200-4000
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.3), 1.0% BSA and 50% Glycerol
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: USP16
Long Name
Ubiquitin Specific Protease 16
Alternate Names
UBP-M
Gene Symbol
USP16
Additional USP16 Products
Product Documents for USP16 Antibody (OTI1B4)
Product Specific Notices for USP16 Antibody (OTI1B4)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...